Common Drugs Use in Ophthalmology Market - Global Outlook and Forecast 2021-2027

April 2021 | 107 pages | ID: CC409E6B0B60EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Common Drugs Use in Ophthalmology in Global, including the following market information:

Global Common Drugs Use in Ophthalmology Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Common Drugs Use in Ophthalmology market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Common Drugs Use in Ophthalmology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Common Drugs Use in Ophthalmology Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Common Drugs Use in Ophthalmology Market Segment Percentages, By Type, 2020 (%)

• Anti-inflammatory Drugs
• Anti-infective Drugs
• Anti-glaucoma Drugs
• Anti-allergy Drugs
• Anti-VEGF Agents
• Others

China Common Drugs Use in Ophthalmology Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Common Drugs Use in Ophthalmology Market Segment Percentages, By Application, 2020 (%)

• Dry Eye
• Glaucoma
• Infection/Inflammation
• Retinal Disorders
• Others

Global Common Drugs Use in Ophthalmology Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Common Drugs Use in Ophthalmology Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Common Drugs Use in Ophthalmology Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Common Drugs Use in Ophthalmology Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Pfizer
• Novartis
• Bausch Health
• Fresenius
• Teva Pharmaceutical
• Allergan
• Mylan
• Santen Pharmaceutical
• Takeda
• Johnson & Johnson
• APOTEX
• GE Medical
• Jamp Pharma
• Senju Pharmaceutical
• Chongqing Chemical & Pharmaceutical Holding (Group) Company
• Sun Pharmaceutical
• Taj Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Common Drugs Use in Ophthalmology Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Common Drugs Use in Ophthalmology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COMMON DRUGS USE IN OPHTHALMOLOGY OVERALL MARKET SIZE

2.1 Global Common Drugs Use in Ophthalmology Market Size: 2021 VS 2027
2.2 Global Common Drugs Use in Ophthalmology Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Common Drugs Use in Ophthalmology Players in Global Market
3.2 Top Global Common Drugs Use in Ophthalmology Companies Ranked by Revenue
3.3 Global Common Drugs Use in Ophthalmology Revenue by Companies
3.4 Top 3 and Top 5 Common Drugs Use in Ophthalmology Companies in Global Market, by Revenue in 2020
3.5 Global Companies Common Drugs Use in Ophthalmology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Common Drugs Use in Ophthalmology Players in Global Market
  3.6.1 List of Global Tier 1 Common Drugs Use in Ophthalmology Companies
  3.6.2 List of Global Tier 2 and Tier 3 Common Drugs Use in Ophthalmology Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Common Drugs Use in Ophthalmology Market Size Markets, 2021 & 2027
  4.1.2 Anti-inflammatory Drugs
  4.1.3 Anti-infective Drugs
  4.1.4 Anti-glaucoma Drugs
  4.1.5 Anti-allergy Drugs
  4.1.6 Anti-VEGF Agents
  4.1.7 Others
4.2 By Type - Global Common Drugs Use in Ophthalmology Revenue & Forecasts
  4.2.1 By Type - Global Common Drugs Use in Ophthalmology Revenue, 2016-2021
  4.2.2 By Type - Global Common Drugs Use in Ophthalmology Revenue, 2022-2027
  4.2.3 By Type - Global Common Drugs Use in Ophthalmology Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Common Drugs Use in Ophthalmology Market Size, 2021 & 2027
  5.1.2 Dry Eye
  5.1.3 Glaucoma
  5.1.4 Infection/Inflammation
  5.1.5 Retinal Disorders
  5.1.6 Others
5.2 By Application - Global Common Drugs Use in Ophthalmology Revenue & Forecasts
  5.2.1 By Application - Global Common Drugs Use in Ophthalmology Revenue, 2016-2021
  5.2.2 By Application - Global Common Drugs Use in Ophthalmology Revenue, 2022-2027
  5.2.3 By Application - Global Common Drugs Use in Ophthalmology Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Common Drugs Use in Ophthalmology Market Size, 2021 & 2027
6.2 By Region - Global Common Drugs Use in Ophthalmology Revenue & Forecasts
  6.2.1 By Region - Global Common Drugs Use in Ophthalmology Revenue, 2016-2021
  6.2.2 By Region - Global Common Drugs Use in Ophthalmology Revenue, 2022-2027
  6.2.3 By Region - Global Common Drugs Use in Ophthalmology Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Common Drugs Use in Ophthalmology Revenue, 2016-2027
  6.3.2 US Common Drugs Use in Ophthalmology Market Size, 2016-2027
  6.3.3 Canada Common Drugs Use in Ophthalmology Market Size, 2016-2027
  6.3.4 Mexico Common Drugs Use in Ophthalmology Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Common Drugs Use in Ophthalmology Revenue, 2016-2027
  6.4.2 Germany Common Drugs Use in Ophthalmology Market Size, 2016-2027
  6.4.3 France Common Drugs Use in Ophthalmology Market Size, 2016-2027
  6.4.4 U.K. Common Drugs Use in Ophthalmology Market Size, 2016-2027
  6.4.5 Italy Common Drugs Use in Ophthalmology Market Size, 2016-2027
  6.4.6 Russia Common Drugs Use in Ophthalmology Market Size, 2016-2027
  6.4.7 Nordic Countries Common Drugs Use in Ophthalmology Market Size, 2016-2027
  6.4.8 Benelux Common Drugs Use in Ophthalmology Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Common Drugs Use in Ophthalmology Revenue, 2016-2027
  6.5.2 China Common Drugs Use in Ophthalmology Market Size, 2016-2027
  6.5.3 Japan Common Drugs Use in Ophthalmology Market Size, 2016-2027
  6.5.4 South Korea Common Drugs Use in Ophthalmology Market Size, 2016-2027
  6.5.5 Southeast Asia Common Drugs Use in Ophthalmology Market Size, 2016-2027
  6.5.6 India Common Drugs Use in Ophthalmology Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Common Drugs Use in Ophthalmology Revenue, 2016-2027
  6.6.2 Brazil Common Drugs Use in Ophthalmology Market Size, 2016-2027
  6.6.3 Argentina Common Drugs Use in Ophthalmology Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Common Drugs Use in Ophthalmology Revenue, 2016-2027
  6.7.2 Turkey Common Drugs Use in Ophthalmology Market Size, 2016-2027
  6.7.3 Israel Common Drugs Use in Ophthalmology Market Size, 2016-2027
  6.7.4 Saudi Arabia Common Drugs Use in Ophthalmology Market Size, 2016-2027
  6.7.5 UAE Common Drugs Use in Ophthalmology Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Common Drugs Use in Ophthalmology Major Product Offerings
  7.1.4 Pfizer Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.1.5 Pfizer Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Common Drugs Use in Ophthalmology Major Product Offerings
  7.2.4 Novartis Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.2.5 Novartis Key News
7.3 Bausch Health
  7.3.1 Bausch Health Corporate Summary
  7.3.2 Bausch Health Business Overview
  7.3.3 Bausch Health Common Drugs Use in Ophthalmology Major Product Offerings
  7.3.4 Bausch Health Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.3.5 Bausch Health Key News
7.4 Fresenius
  7.4.1 Fresenius Corporate Summary
  7.4.2 Fresenius Business Overview
  7.4.3 Fresenius Common Drugs Use in Ophthalmology Major Product Offerings
  7.4.4 Fresenius Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.4.5 Fresenius Key News
7.5 Teva Pharmaceutical
  7.5.1 Teva Pharmaceutical Corporate Summary
  7.5.2 Teva Pharmaceutical Business Overview
  7.5.3 Teva Pharmaceutical Common Drugs Use in Ophthalmology Major Product Offerings
  7.5.4 Teva Pharmaceutical Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.5.5 Teva Pharmaceutical Key News
7.6 Allergan
  7.6.1 Allergan Corporate Summary
  7.6.2 Allergan Business Overview
  7.6.3 Allergan Common Drugs Use in Ophthalmology Major Product Offerings
  7.6.4 Allergan Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.6.5 Allergan Key News
7.7 Mylan
  7.7.1 Mylan Corporate Summary
  7.7.2 Mylan Business Overview
  7.7.3 Mylan Common Drugs Use in Ophthalmology Major Product Offerings
  7.4.4 Mylan Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.7.5 Mylan Key News
7.8 Santen Pharmaceutical
  7.8.1 Santen Pharmaceutical Corporate Summary
  7.8.2 Santen Pharmaceutical Business Overview
  7.8.3 Santen Pharmaceutical Common Drugs Use in Ophthalmology Major Product Offerings
  7.8.4 Santen Pharmaceutical Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.8.5 Santen Pharmaceutical Key News
7.9 Takeda
  7.9.1 Takeda Corporate Summary
  7.9.2 Takeda Business Overview
  7.9.3 Takeda Common Drugs Use in Ophthalmology Major Product Offerings
  7.9.4 Takeda Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.9.5 Takeda Key News
7.10 Johnson & Johnson
  7.10.1 Johnson & Johnson Corporate Summary
  7.10.2 Johnson & Johnson Business Overview
  7.10.3 Johnson & Johnson Common Drugs Use in Ophthalmology Major Product Offerings
  7.10.4 Johnson & Johnson Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.10.5 Johnson & Johnson Key News
7.11 APOTEX
  7.11.1 APOTEX Corporate Summary
  7.11.2 APOTEX Business Overview
  7.11.3 APOTEX Common Drugs Use in Ophthalmology Major Product Offerings
  7.11.4 APOTEX Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.11.5 APOTEX Key News
7.12 GE Medical
  7.12.1 GE Medical Corporate Summary
  7.12.2 GE Medical Business Overview
  7.12.3 GE Medical Common Drugs Use in Ophthalmology Major Product Offerings
  7.12.4 GE Medical Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.12.5 GE Medical Key News
7.13 Jamp Pharma
  7.13.1 Jamp Pharma Corporate Summary
  7.13.2 Jamp Pharma Business Overview
  7.13.3 Jamp Pharma Common Drugs Use in Ophthalmology Major Product Offerings
  7.13.4 Jamp Pharma Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.13.5 Jamp Pharma Key News
7.14 Senju Pharmaceutical
  7.14.1 Senju Pharmaceutical Corporate Summary
  7.14.2 Senju Pharmaceutical Business Overview
  7.14.3 Senju Pharmaceutical Common Drugs Use in Ophthalmology Major Product Offerings
  7.14.4 Senju Pharmaceutical Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.14.5 Senju Pharmaceutical Key News
7.15 Chongqing Chemical & Pharmaceutical Holding (Group) Company
  7.15.1 Chongqing Chemical & Pharmaceutical Holding (Group) Company Corporate Summary
  7.15.2 Chongqing Chemical & Pharmaceutical Holding (Group) Company Business Overview
  7.15.3 Chongqing Chemical & Pharmaceutical Holding (Group) Company Common Drugs Use in Ophthalmology Major Product Offerings
  7.15.4 Chongqing Chemical & Pharmaceutical Holding (Group) Company Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.15.5 Chongqing Chemical & Pharmaceutical Holding (Group) Company Key News
7.16 Sun Pharmaceutical
  7.16.1 Sun Pharmaceutical Corporate Summary
  7.16.2 Sun Pharmaceutical Business Overview
  7.16.3 Sun Pharmaceutical Common Drugs Use in Ophthalmology Major Product Offerings
  7.16.4 Sun Pharmaceutical Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.16.5 Sun Pharmaceutical Key News
7.17 Taj Pharmaceuticals
  7.17.1 Taj Pharmaceuticals Corporate Summary
  7.17.2 Taj Pharmaceuticals Business Overview
  7.17.3 Taj Pharmaceuticals Common Drugs Use in Ophthalmology Major Product Offerings
  7.17.4 Taj Pharmaceuticals Common Drugs Use in Ophthalmology Revenue in Global (2016-2021)
  7.17.5 Taj Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Common Drugs Use in Ophthalmology Market Opportunities & Trends in Global Market
Table 2. Common Drugs Use in Ophthalmology Market Drivers in Global Market
Table 3. Common Drugs Use in Ophthalmology Market Restraints in Global Market
Table 4. Key Players of Common Drugs Use in Ophthalmology in Global Market
Table 5. Top Common Drugs Use in Ophthalmology Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Common Drugs Use in Ophthalmology Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Common Drugs Use in Ophthalmology Revenue Share by Companies, 2016-2021
Table 8. Global Companies Common Drugs Use in Ophthalmology Product Type
Table 9. List of Global Tier 1 Common Drugs Use in Ophthalmology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Common Drugs Use in Ophthalmology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Common Drugs Use in Ophthalmology Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Common Drugs Use in Ophthalmology Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Common Drugs Use in Ophthalmology Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Common Drugs Use in Ophthalmology Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Common Drugs Use in Ophthalmology Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Common Drugs Use in Ophthalmology Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2022-2027
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Common Drugs Use in Ophthalmology Product Offerings
Table 32. Pfizer Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)
Table 33. Novartis Corporate Summary
Table 34. Novartis Common Drugs Use in Ophthalmology Product Offerings
Table 35. Novartis Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)
Table 36. Bausch Health Corporate Summary
Table 37. Bausch Health Common Drugs Use in Ophthalmology Product Offerings
Table 38. Bausch Health Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)
Table 39. Fresenius Corporate Summary
Table 40. Fresenius Common Drugs Use in Ophthalmology Product Offerings
Table 41. Fresenius Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)
Table 42. Teva Pharmaceutical Corporate Summary
Table 43. Teva Pharmaceutical Common Drugs Use in Ophthalmology Product Offerings
Table 44. Teva Pharmaceutical Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)
Table 45. Allergan Corporate Summary
Table 46. Allergan Common Drugs Use in Ophthalmology Product Offerings
Table 47. Allergan Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)
Table 48. Mylan Corporate Summary
Table 49. Mylan Common Drugs Use in Ophthalmology Product Offerings
Table 50. Mylan Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)
Table 51. Santen Pharmaceutical Corporate Summary
Table 52. Santen Pharmaceutical Common Drugs Use in Ophthalmology Product Offerings
Table 53. Santen Pharmaceutical Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)
Table 54. Takeda Corporate Summary
Table 55. Takeda Common Drugs Use in Ophthalmology Product Offerings
Table 56. Takeda Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)
Table 57. Johnson & Johnson Corporate Summary
Table 58. Johnson & Johnson Common Drugs Use in Ophthalmology Product Offerings
Table 59. Johnson & Johnson Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)
Table 60. APOTEX Corporate Summary
Table 61. APOTEX Common Drugs Use in Ophthalmology Product Offerings
Table 62. APOTEX Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)
Table 63. GE Medical Corporate Summary
Table 64. GE Medical Common Drugs Use in Ophthalmology Product Offerings
Table 65. GE Medical Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)
Table 66. Jamp Pharma Corporate Summary
Table 67. Jamp Pharma Common Drugs Use in Ophthalmology Product Offerings
Table 68. Jamp Pharma Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)
Table 69. Senju Pharmaceutical Corporate Summary
Table 70. Senju Pharmaceutical Common Drugs Use in Ophthalmology Product Offerings
Table 71. Senju Pharmaceutical Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)
Table 72. Chongqing Chemical & Pharmaceutical Holding (Group) Company Corporate Summary
Table 73. Chongqing Chemical & Pharmaceutical Holding (Group) Company Common Drugs Use in Ophthalmology Product Offerings
Table 74. Chongqing Chemical & Pharmaceutical Holding (Group) Company Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)
Table 75. Sun Pharmaceutical Corporate Summary
Table 76. Sun Pharmaceutical Common Drugs Use in Ophthalmology Product Offerings
Table 77. Sun Pharmaceutical Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)
Table 78. Taj Pharmaceuticals Corporate Summary
Table 79. Taj Pharmaceuticals Common Drugs Use in Ophthalmology Product Offerings
Table 80. Taj Pharmaceuticals Common Drugs Use in Ophthalmology Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Common Drugs Use in Ophthalmology Segment by Type
Figure 2. Common Drugs Use in Ophthalmology Segment by Application
Figure 3. Global Common Drugs Use in Ophthalmology Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Common Drugs Use in Ophthalmology Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Common Drugs Use in Ophthalmology Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Common Drugs Use in Ophthalmology Revenue in 2020
Figure 8. By Type - Global Common Drugs Use in Ophthalmology Revenue Market Share, 2016-2027
Figure 9. By Application - Global Common Drugs Use in Ophthalmology Revenue Market Share, 2016-2027
Figure 10. By Region - Global Common Drugs Use in Ophthalmology Revenue Market Share, 2016-2027
Figure 11. By Country - North America Common Drugs Use in Ophthalmology Revenue Market Share, 2016-2027
Figure 12. US Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Common Drugs Use in Ophthalmology Revenue Market Share, 2016-2027
Figure 16. Germany Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 17. France Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Common Drugs Use in Ophthalmology Revenue Market Share, 2016-2027
Figure 24. China Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 28. India Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Common Drugs Use in Ophthalmology Revenue Market Share, 2016-2027
Figure 30. Brazil Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Common Drugs Use in Ophthalmology Revenue Market Share, 2016-2027
Figure 33. Turkey Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Common Drugs Use in Ophthalmology Revenue, (US$, Mn), 2016-2027
Figure 37. Pfizer Common Drugs Use in Ophthalmology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Novartis Common Drugs Use in Ophthalmology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Bausch Health Common Drugs Use in Ophthalmology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Fresenius Common Drugs Use in Ophthalmology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Teva Pharmaceutical Common Drugs Use in Ophthalmology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Allergan Common Drugs Use in Ophthalmology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Mylan Common Drugs Use in Ophthalmology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Santen Pharmaceutical Common Drugs Use in Ophthalmology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Takeda Common Drugs Use in Ophthalmology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Johnson & Johnson Common Drugs Use in Ophthalmology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. APOTEX Common Drugs Use in Ophthalmology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. GE Medical Common Drugs Use in Ophthalmology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Jamp Pharma Common Drugs Use in Ophthalmology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Senju Pharmaceutical Common Drugs Use in Ophthalmology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Chongqing Chemical & Pharmaceutical Holding (Group) Company Common Drugs Use in Ophthalmology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Sun Pharmaceutical Common Drugs Use in Ophthalmology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)